Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
Phase 2
Completed
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Interventions
- Drug: Placebo to match NRD135S.E1
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Novaremed Ltd.
- Target Recruit Count
- 88
- Registration Number
- NCT02345291
- Locations
- 🇮🇱
Sorasky Medical Center, Diabetic unit, Tel-Aviv, Israel
🇮🇱Diabetes and Endocrinology clinic, Bat-Yamon Medical center, Clalit health services, Bat-Yam, Israel
🇮🇱Rambam Medical Center, Diabetic Endocrine unit, Haifa, Israel
© Copyright 2025. All Rights Reserved by MedPath